CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer

Gallbladder cancer (GBC) is one of the most common and aggressive biliary tract cancers with a dismal prognosis. Ongoing clinical trials are evaluating a few selected immune checkpoint inhibitors (ICIs) as monotherapy for the treatment of GBC patients. However, only a subset of patients benefits fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lu, Bridle, Kim R., Shrestha, Ritu, Prithviraj, Prashanth, Crawford, Darrell H. G., Jayachandran, Aparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836068/
https://www.ncbi.nlm.nih.gov/pubmed/35163489
http://dx.doi.org/10.3390/ijms23031565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836068/
https://www.ncbi.nlm.nih.gov/pubmed/35163489
http://dx.doi.org/10.3390/ijms23031565

Ejemplares similares